Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Venous thromboembolic disease.

R D Hull1, G E Raskob

  • 1University of Calgary, Alberta, Canada.

Current Opinion in Cardiology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Recent clinical trials advance venous thromboembolism care. New diagnostic tools and treatments improve outcomes for deep vein thrombosis and pulmonary embolism, while enhancing prevention strategies for high-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Thrombosis: a major contributor to global disease burden.

Arteriosclerosis, thrombosis, and vascular biology·2014
Same author

Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.

The Journal of bone and joint surgery. British volume·2012
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Clinical Trials

Background:

  • Venous thromboembolism (VTE) diagnosis and treatment require continuous updates.
  • Clinical trials are crucial for advancing patient care in VTE management.

Purpose of the Study:

  • To summarize recent clinical trial findings impacting VTE care.
  • To highlight advances in VTE diagnosis, treatment, and prevention.

Main Methods:

  • Review of recent clinical trial publications.
  • Analysis of diagnostic test efficacy and treatment protocols.
  • Evaluation of preventative measures in high-risk populations.

Main Results:

  • Established roles for ventilation-perfusion lung scanning and objective deep vein thrombosis (DVT) tests in pulmonary embolism (PE) diagnosis.

Related Experiment Videos

  • Demonstrated effectiveness of impedance plethysmography in pregnant patients and Doppler ultrasound for DVT diagnosis.
  • Determined optimal duration for initial intravenous heparin therapy.
  • Confirmed effectiveness of sequential intermittent compression for hip replacement patients and provided further data on low-molecular-weight heparin for high-risk VTE prevention.

    • Conclusions:

    • Recent clinical trials have significantly improved diagnostic accuracy for VTE.
    • Evidence supports enhanced treatment strategies and effective preventative measures for VTE.
    • These advancements collectively improve the management and outcomes for patients with venous thromboembolism.